Prior to the 1970s, researchers widely believed cervical cancer was caused by the herpes simplex virus. That understanding ...

Italian pharma Alfasigma has penned a 125 million euro ($145 million) deal for the rights to an injectable form of an investigational herpes simplex virus (HSV) encephalitis treatment. | Italian ...

Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a ...

Adibelivir is a next generation helicase-primase inhibitor. The oral formulation is advancing toward Phase 2 development for genital herpes, while the parenteral formulation is dedicated exclusively ...

Herpes is common – and manageable. Here's how it can affect pregnancy, birth, and your baby, plus what you can do to protect ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to ...

A young woman was left suffering from a seizure and brain swelling after being infected with a common virus carried by 50million Americans. The 30-year-old was otherwise healthy when she suddenly lost ...

This is read by an automated voice. Please report any issues or inconsistencies here. Cancer-fighting, genetically engineered herpes simplex virus has been shown to be an effective treatment for ...

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of treatment, compared with standard-of-care (SoC) treatments ...

Approximately two-thirds of the world's population under the age of 50 years have oral or genital herpes simplex type 1 (HSV-1) infection, while one in eight have herpes simplex type 2 (HSV-2) ...

Assembly Biosciences (NASDAQ:ASMB) reported promising results from an early stage study of its experimental candidate, ABI-5366, a new treatment aimed against herpes simplex virus. This study involved ...